BIOTRICITY INC. (BTCY) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US09074H1041

Price
0.06 USD
Market cap
1.19 m USD
P/E (2026)
–
P/S (2026)
0.07
Dividend yield
0.00 %
Net margin
-15.03 %
Return on equity (ROE)
6.93 %
Return on assets (ROA)
–

BIOTRICITY INC. financials

Fiscal year20252026
Revenue13.79 m USD16.00 m USD
Gross profit10.56 m USD12.95 m USD
Operating income-2.45 m USD1.69 m USD
EBIT-5.16 m USD957,811.00 USD
Net income-8.42 m USD-2.40 m USD
Diluted EPS – continuing operations-0.56 USD-0.12 USD

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BIOTRICITY INC.

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.